Sofinnova Venture Partners IX L.P. 13D and 13G filings for NextCure, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-05 06:06 am Sale | 2025-12-19 | 13D | NEXTCURE INC NXTC | Sofinnova Venture Partners IX L.P. | 222,654 7.100% | -2,449,202 (-91.67%) | Filing |